Ünal, Ç. Et Al. 2023. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group. The oncologist , vol.28, no.10 , 875-884.

Ünal, Ç., AZİZY, A., KARABULUT, S., TAŞTEKİN, D., AKYILDIZ, A., YAŞAR, S., ... YALÇIN, Ş.(2023). Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group. The oncologist , vol.28, no.10, 875-884.

Ünal, Çağlar Et Al. "Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group," The oncologist , vol.28, no.10, 875-884, 2023

Ünal, Çağlar Et Al. "Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group." The oncologist , vol.28, no.10, pp.875-884, 2023

Ünal, Ç. Et Al. (2023) . "Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group." The oncologist , vol.28, no.10, pp.875-884.

@article{article, author={Çağlar Ünal Et Al. }, title={Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group}, journal={The oncologist}, year=2023, pages={875-884} }